Brickell, Bodor settlement talks falter

BOULDER and MIAMI — Efforts to settle an intellectual-property dispute between Boulder’s Brickell Biotech Inc. (Nasdaq: BBI) and Miami-based Bodor Laboratories Inc. failed this week, triggering arbitration.

Brickell said mediation talks between the two companies has “proven unsuccessful” and are proceeding toward a binding arbitration process, according to disclosures made to the U.S. Securities and Exchange Commission Monday.

Bodor sued Brickell in late October, alleging a series of intellectual-property violations for an anti-excessive-sweating treatment. Brickell has long said Bodor’s claims are without merit.

The suit was later stayed when Brickell triggered an…